Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: Establishing criteria for optimal chelators

被引:40
作者
Goldwaser, I
Qian, S
Gershonov, E
Fridkin, M
Shechter, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel
关键词
D O I
10.1124/mol.58.4.738
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several ligands, when complexed with vanadium, potentiate its insulinomimetic activity both in vivo and in vitro. We have recently found that L-Glu-gamma-monohydroxamate (HXM) and L-Asp(beta)HXM were especially potent in this regard. In the present study, we used vanadium-enriched adipose cells and cell-free experimental systems to determine the features of L-Glu(gamma)HXM and L-Asp(beta) HXM that turn these ligands into optimal-synergizing vanadium chelators. We found that L- Glu(gamma) HXM and L-Asp(beta)( HXM) possess the following characteristics: 1) They associate with vanadium( +5) at pH 7.2 within a narrow range of an apparent formation constant of 1.3 to 1.9 x 10(2) M-1; 2) they have nearly the same binding affinity for the vanadyl(+4) cation and the vanadate(+5) anion at physiological pH values; and 3) they form intense ultraviolet absorbing complexes upon associating with vanadium(+4) at 1 and 3 M stoichiometry, respectively, at pH 3.0. Vanadium ligands lacking any of these three defined criteria synergize less effectively with vanadium to activate glucose metabolism.
引用
收藏
页码:738 / 746
页数:9
相关论文
共 37 条
[1]   THE ROLE OF VANADIUM IN THE MANAGEMENT OF DIABETES [J].
BRICHARD, SM ;
HENQUIN, JC .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (08) :265-270
[2]  
Butler A., 1990, VANADIUM BIOL SYSTEM, P25, DOI [10.1007/978-94-009-2023-1_2, DOI 10.1007/978-94-009-2023-1_2]
[3]  
Caravan P, 1995, J AM CHEM SOC, V117, P12759
[4]   ORAL VANADYL SULFATE IMPROVES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN PATIENTS WITH NON-LNSULIN-DEPENDENT DIABETES-MELLITUS [J].
COHEN, N ;
HALBERSTAM, M ;
SHLIMOVICH, P ;
CHANG, CJ ;
SHAMOON, H ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2501-2509
[5]  
Crans D.C., 1994, COMMENT INORG CHEM, V16, P1, DOI 10.1080/02603599408035850
[6]   INTERACTION OF TRACE LEVELS OF VANADIUM(IV) AND VANADIUM(V) IN BIOLOGICAL-SYSTEMS [J].
CRANS, DC ;
BUNCH, RL ;
THEISEN, LA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (19) :7597-7607
[7]  
ELBERG G, 1994, J BIOL CHEM, V269, P9521
[8]   Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes [J].
Elberg, G ;
He, ZB ;
Li, JP ;
Sekar, N ;
Shechter, Y .
DIABETES, 1997, 46 (11) :1684-1690
[9]   PERVANADATE [PEROXIDE(S) OF VANADATE] MIMICS INSULIN ACTION IN RAT ADIPOCYTES VIA ACTIVATION OF THE INSULIN-RECEPTOR TYROSINE KINASE [J].
FANTUS, IG ;
KADOTA, S ;
DERAGON, G ;
FOSTER, B ;
POSNER, BI .
BIOCHEMISTRY, 1989, 28 (22) :8864-8871
[10]   In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus [J].
Goldfine, AB ;
Simonson, DC ;
Folli, F ;
Patti, E ;
Kahn, CR .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 153 (1-2) :217-231